Navigation Links
Ixoreal Biomed "Adopts" Ashwagandha through the American Botanical Council

AUSTIN, Texas, Nov. 11, 2013 /PRNewswire-USNewswire/ -- The American Botanical Council (ABC) is pleased to announce that Ixoreal Biomed, an herbal extracts and pharmaceuticals company based in Los Angeles, CA, and Hyderabad, India, has adopted the highly revered traditional herb ashwagandha (Withania somnifera) through ABC's Adopt-an-Herb Program.


Ixoreal Biomed's three-year commitment helps ABC keep its HerbMedPro™ database up-to-date with the latest scientific and clinical research on ashwagandha. HerbMedPro is an interactive and comprehensive database available on ABC's website that provides access to important scientific and clinical research data underlying the use of nearly 250 herbs and their effects on human health.

"ABC is deeply grateful for Ixoreal Biomed's support, which is crucial to continuing our nonprofit educational mission," said ABC Founder and Executive Director Mark Blumenthal. "Numerous health benefits of ashwagandha have been documented for hundreds, if not thousands, of years. It is well-known in Ayurveda and other systems of traditional medicine in India. The plant's traditional reputation as a tonic has led to a growing body of modern research. ABC is looking forward to partnering with Ixoreal Biomed to take stewardship of abstracts on current and forthcoming scientific publications on this valuable herb."

Ixoreal Biomed joins 21 additional herb- and plant-based ingredient companies that support ongoing efforts through ABC's Adopt-an-Herb Program to collect, organize, and disseminate reliable, traditional, science-based, and clinical information on herbs, medicinal plants, and other botanical- and fungal-based ingredients. Adopt-an-Herb encourages companies and individuals to "adopt" one or more specific herbs for inclusion and ongoing maintenance in the HerbMedPro database. To date, 24 herbs have been adopted. Each adopted herb is continuously researched for new articles and studies, ensuring that its HerbMedPro record stays current and robust. The result is an unparalleled resource — not only for researchers, health professionals, industry, and consumers, but for all members of the herbal and dietary supplements community, and others — available via ABC's information-rich website. In keeping with ABC's position as an independent nonprofit organization, herb adopters do not influence the scientific information that is compiled for their respective adopted herbs.

HerbMedPro provides online access to abstracts of scientific and clinical publications on nearly 250 commonly used medicinal herbs. Herb records in the database vary in size from those with a large amount of published data — such as Ginkgo biloba, with more than 1,000 summarized entries and links — to Acacia catechu (cutch tree or black catechu in the pea family), with fewer than 50. Each abstract also is summarized in only one sentence, thereby saving users a significant amount of time.

HerbMedPro is available to ABC members at the Academic level and higher; its "sister" site HerbMed®, however, is free and available to the general public. HerbMed features 20-to-30 herbs from HerbMedPro that are rotated on a regular basis. Making this unique resource free to the public increases the number of people who benefit from updated information on herbs, in accordance with ABC's nonprofit educational mission.

About Ashwagandha

Ashwagandha, a much-revered plant in traditional Ayurvedic medicine, is cultivated throughout India and much of Asia and grows to three-to-five feet tall. The root is used as an adaptogen, meaning it helps the body to cope with stress. Ashwagandha has a wide variety of traditional uses, including as a hypnotic, laxative, and tonic. In fact, the name "ashwagandha" comes from the Sanskrit word for "smells like a horse" or "horse essence," a reference to the traditional belief that the root provides the strength, character, essence, or stamina of a horse. Modern medicinal uses of ashwagandha preparations include treatment of inflammation, wasting diseases, and arthritis. Within the last few years, several clinical trials have been conducted to test the herb's efficacy in treating infertility, tuberculosis, and anxiety, among other conditions; some trials have produced positive outcomes. In 2008, India's Department of Ayurveda, Yoga & Naturopathy, Unani, Siddha and Homeopathy (AYUSH) chose to promote ashwagandha preparations as part of a global strategy for brand-building of Ayurvedic medicine in Western countries. Ashwagandha preparations can be found in dozens of dietary supplements and related products throughout Australia, Canada, the United States, and other countries. More information on ashwagandha can be found in this profile from HerbalGram issue 99.

About Ixoreal Biomed

Ixoreal Biomed is an herbal extracts and pharmaceuticals company based in Los Angeles, CA, and Hyderabad, India. Ixoreal is focused solely on producing a high-quality extract of ashwagandha called KSM-66®. Ixoreal has developed a proprietary process that integrates modern scientific technologies with traditional Ayurvedic concepts to produce a highly concentrated full-spectrum ashwagandha root extract. Ixoreal has invested heavily in basic research and development and in building a modern scientific repository of efficacy data on ashwagandha. To this end, Ixoreal has conducted seven human clinical trials and two animal studies on the effectiveness of ashwagandha in several important functional areas. Ixoreal describes itself as the only ashwagandha manufacturer in the world that is entirely vertically integrated with its own farms, production facilities, testing laboratories, research center, and distribution division. More information is available at

About the American Botanical Council

Founded in 1988, the American Botanical Council is a leading international nonprofit organization that addresses research and educational issues regarding herbs, teas, medicinal plants, essential oils, and other beneficial plant-derived materials. ABC's members include academic researchers and educators; libraries; health professionals and medical institutions; government agencies; members of the herb, dietary supplement, cosmetic, and pharmaceutical industries; journalists; consumers; and others in more than 80 countries. The organization occupies a historic 2.5-acre site in Austin, Texas, where it publishes the peer-reviewed quarterly journal HerbalGram, the monthly e-publication HerbalEGram, the weekly e-newsletter Herbal News & Events, HerbClips (summaries of scientific and clinical publications), reference books, and other educational materials. ABC also hosts HerbMedPro, a powerful herbal database, covering scientific and clinical publications on more than 250 herbs. ABC also co-produces the "Herbal Insights" segment for Healing Quest, a television series on PBS.

ABC is tax-exempt under section 501(c)(3) of the IRS Code. Information: Contact ABC at P.O. Box 144345, Austin, TX 78714-4345, Phone: 512-926-4900. Website: Contact: Public Relations.

Contact: Sara O'Connor, 512-926-4900

SOURCE American Botanical Council
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Cellular Biomedicine Group Announces Adjournment of Its Annual Shareholder Meeting
2. Cellular Biomedicine Group Announces Completion of Patient Treatment for Phase I/IIa Clinical Trial for Treatment of Knee Osteoarthritis (KOA)
3. New Hudsonville-Based Biomedical Startup, Imago Prints, Uses Patient-Specific Ultrasound Data to Produce One-of-a-Kind 3D Printed Renderings of Infants During Pregnancy
4. Cellular Biomedicine Group Announces New Product Approved for Market in China and New Exclusive License
5. West Michigan Based Biomedical Company, Engineering 4 Life, Offers Services Using Patient Specific Data to Aid Medical Professionals and Provide Effective Medical Designs
6. New 62,600 Square Foot Lease At 650 East Kendall Street Signed By Ipsen And BioMed Realty
7. Young scientists receive NSBRI space biomedical research fellowships
8. Avon Foundation for Women, NIH, and the Center for Advancing Innovation Launch Start-Up Challenge to Advance Breast Cancer Biomedical Invention
9. VIVEX BIOMEDICAL Successfully Completes $7.6 Million Round of Financing
10. Topical BioMedics, Inc., Signs on With CVS Pharmacy; Topricin® Foot Therapy Cream to be Carried in the Retailer’s Foot Care Section
11. H3 Biomedicine and Selvita Announce Strategic Collaboration to Develop Precision Cancer Medicines
Post Your Comments:
(Date:11/24/2015)... ... November 24, 2015 , ... ... the year and one of the premier annual events for pharmaceutical manufacturing: 2015 ... 8–11 November 2015, where ISPE hosted the largest number of attendees in more ...
(Date:11/24/2015)... , November 24, 2015 ... new market research report "Oligonucleotide Synthesis Market by Product ... (PCR, Gene Synthesis, Diagnostic, DNA, RNAi), End-User (Research, Pharmaceutical ... published by MarketsandMarkets, the market is expected to reach ... in 2015, at a CAGR of 10.1% during the ...
(Date:11/24/2015)... November 24, 2015 SHPG ) announced today ... the Piper Jaffray 27 th Annual Healthcare Conference in ... 2015, at 8:30 a.m. EST (1:30 p.m. GMT). --> ... Officer, will participate in the Piper Jaffray 27 th Annual ... on Tuesday, December 1, 2015, at 8:30 a.m. EST (1:30 p.m. ...
(Date:11/24/2015)... QUEBEC CITY , Nov. 24, 2015 /PRNewswire/ ... (the "Company") announced today that the remaining 11,000 ... Common Share Purchase Warrants (the "Series B Warrants") ... agreement were exercised on November 23, 2015, which ... Common Shares.  After giving effect to the issuance ...
Breaking Biology Technology:
(Date:11/12/2015)... BOSTON , Nov. 12, 2015  A golden ... for Duchenne muscular dystrophy (DMD) has provided a new ... Boston Children,s Hospital, the Broad Institute of MIT and ... Brazil . Cell, ... some dogs "escape" the disease,s effects. The Boston Children,s ...
(Date:11/10/2015)... , Nov. 10, 2015  In ... on the basis of product, type, application, ... included in this report are consumables, services, ... report are safety biomarkers, efficacy biomarkers, and ... this report are diagnostics development, drug discovery ...
(Date:11/4/2015)... New York , November 4, 2015 ... to a new market report published by Transparency Market ... Share, Growth, Trends and Forecast 2015 - 2022", the global ... of US$ 30.3 bn by 2022. The market is ... the forecast period from 2015 to 2022. Rising security ...
Breaking Biology News(10 mins):